Clearpoint Neuro

Yahoo Finance • 7 days ago

ClearPoint Neuro Surges Nearly 40% - Can The Stock Retest Its 52-week High?

(RTTNews) - Shares of ClearPoint Neuro Inc. (CLPT) are up nearly 40% at $17 in premarket trading on Wednesday. This global device, cell, and gene therapy-enabling company operates in two segments: (i) a business providing medical devices... Full story

Yahoo Finance • 2 months ago

ClearPoint Neuro outlines global expansion plans and anticipates regulatory milestones while advancing cell and gene therapy initiatives

Earnings Call Insights: ClearPoint Neuro (CLPT) Q2 2025 MANAGEMENT VIEW * Joseph Michael Burnett, CEO, described 2025 as the start of ClearPoint Neuro’s “third phase,” called Fast. Forward., emphasizing an expanded commitment to cell a... Full story

Yahoo Finance • 2 months ago

ClearPoint Neuro Inc (NASDAQ:CLPT) Reports Mixed Q2 2025 Results with Record Revenue but Narrow EPS Miss

CLEARPOINT NEURO REPORTS MIXED Q2 2025 RESULTS AMID STRATEGIC EXPANSION CLEARPOINT NEURO INC (NASDAQ:CLPT [https://www.chartmill.com/stock/quote/CLPT]) announced its second-quarter 2025 financial results, delivering record revenue but fal... Full story

Yahoo Finance • 2 months ago

Here are the major earnings after the close Tuesday

Major earnings expected after the bell on Tuesday include: * CoreWeave (CRWV [https://seekingalpha.com/symbol/CRWV]) * Inovio Pharmaceuticals (INO [https://seekingalpha.com/symbol/INO]) * Luminar Technologies (LAZR [https://seekinga... Full story

Yahoo Finance • 4 months ago

ClearPoint Neuro May 2025 presentation: Enters 'Fast Forward' phase after Q1 revenue beat

Introduction & Market Context ClearPoint Neuro Inc. (NASDAQ:CLPT) unveiled its corporate presentation on May 13, 2025, highlighting the company’s strategic vision as it enters what management calls the "Fast Forward" phase of its developm... Full story

Yahoo Finance • 2 years ago

ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023

SOLANA BEACH, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will releas... Full story

Yahoo Finance • 2 years ago

ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference

SOLANA BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management... Full story

Yahoo Finance • 2 years ago

ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles

SOLANA BEACH, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced it will present inve... Full story

Yahoo Finance • 2 years ago

ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023

SOLANA BEACH, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will relea... Full story

Yahoo Finance • 2 years ago

ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model

SOLANA BEACH, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced an exclusive world... Full story

Yahoo Finance • 2 years ago

A ClearPoint Neuro Anuncia Aprovação da Carteira de Navegação Neuro pela ANVISA no Brasil

SOLANA BEACH, Califórnia, April 13, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (a "Empresa"), uma empresa de plataforma global que fornece navegação e entrega ao cérebro, anunciou hoje o registo bem sucedido da sua ca... Full story

Yahoo Finance • 2 years ago

ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil

SOLANA BEACH, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced successful registr... Full story

Yahoo Finance • 2 years ago

ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS

SOLANA BEACH, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced further expansion... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro annonce un accord de licence exclusif pluriannuel avec l'UCSF concernant une plateforme innovante pour l'administration cellulaire intracérébrale

SOLANA BEACH, Californie, 28 mars 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ : CLPT) (la « Société »), une société mondiale de plateformes thérapeutiques permettant la navigation et l'administration vers le cerveau, annonce... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro gibt exklusive mehrjährige Lizenzvereinbarung mit UCSF für innovative intrazerebrale Zellverabreichungsplattform bekannt

SOLANA BEACH, Kalifornien, March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (das „Unternehmen“), ein weltweites Unternehmen für therapieermöglichende Plattformen, das die Navigation zum und die Verabreichung im Ge... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform

SOLANA BEACH, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced an exclusive multi... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results

SOLANA BEACH, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue

SOLANA BEACH, Calif., Jan. 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced preliminary, unaudi... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro Announces First Patient Enrolled in Glioblastoma Trial Using ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Sweden

SOLANA BEACH, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced enrollment of the f... Full story

Yahoo Finance • 3 years ago

ClearPoint Neuro to Present at Upcoming Investor Conferences

SOLANA BEACH, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management... Full story